Imunon, Inc. (IMNN)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 50K 100K 150K Q1 '18: 125K Q2 '18: 125K Q3 '18: 125K Q4 '18: 125K Q1 '19: 125K Q2 '19: 125K Q3 '19: 125K Q4 '19: 125K Q1 '20: 125K Q2 '20: 125K Q3 '20: 125K Q4 '20: 125K Q1 '21: 125K Q2 '21: 125K Q3 '21: 125K Q4 '21: 125K Q1 '22: 125K Q2 '22: 125K Q3 '22: 125K Q4 '22: 125K Q2 '18 Q1 '19 Q4 '19 Q3 '20 Q2 '21 Q1 '22 Q4 '22

Gross Profit Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Income Quarterly

-7.5M -5M -2.5M 0 2.5M 5M 7.5M Q3 '21: -5.1M Q4 '21: -5.5M Q1 '22: -5.8M Q2 '22: -6M Q3 '22: -6.2M Q4 '22: -6.9M Q1 '23: -5.7M Q2 '23: -5.5M Q3 '23: -3.9M Q4 '23: -6M Q1 '24: -5M Q2 '24: -5M Q3 '24: -5M Q4 '24: -4.1M Q1 '25: -4.1M Q2 '25: -2.8M Q3 '25: -3.5M Q4 '25: -4.3M Q1 '26: -4.3M Q2 '26: -2.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Net Income Quarterly

-15M -10M -5M 0 5M 10M 15M Q3 '21: -5.4M Q4 '21: -4.2M Q1 '22: -10.5M Q2 '22: -6M Q3 '22: -6.1M Q4 '22: -13.2M Q1 '23: -5.6M Q2 '23: -5.6M Q3 '23: -3.5M Q4 '23: -4.9M Q1 '24: -4.9M Q2 '24: -4.8M Q3 '24: -4.8M Q4 '24: -4.1M Q1 '25: -4.1M Q2 '25: -2.7M Q3 '25: -3.4M Q4 '25: -4.2M Q1 '26: -4.2M Q2 '26: -2.8M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Cost of Revenue Quarterly

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Quarterly

-9M -6M -3M 0 3M 6M 9M Q3 '21: -3.8M Q4 '21: -5.1M Q1 '22: -8M Q2 '22: -5.5M Q3 '22: -4.6M Q4 '22: -5M Q1 '23: -4M Q2 '23: -6.8M Q3 '23: -4.5M Q4 '23: -3.8M Q1 '24: -5.9M Q2 '24: -4.5M Q3 '24: -4.1M Q4 '24: -4.4M Q1 '25: -2.8M Q2 '25: -3M Q3 '25: -4.4M Q4 '25: -3.7M Q1 '26: -4M Q2 '26: -3M Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

Free Cash Flow Quarterly

-9M -6M -3M 0 3M 6M 9M Q1 '21: -4.9M Q2 '21: -2.7M Q3 '21: -3.8M Q4 '21: -5.1M Q1 '22: -8M Q2 '22: -5.6M Q3 '22: -4.7M Q4 '22: -5.1M Q1 '23: -4M Q2 '23: -6.9M Q3 '23: -4.7M Q4 '23: -3.8M Q1 '24: -5.9M Q2 '24: -4.5M Q3 '24: -4.1M Q4 '24: -4.4M Q1 '25: -3.1M Q2 '25: -3M Q3 '25: -4.4M Q4 '25: -3.7M Q2 '21 Q1 '22 Q4 '22 Q3 '23 Q2 '24 Q1 '25 Q4 '25

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 15M 30M 45M Q2 '12: 33.2M Q2 '13: 13.6M Q2 '14: 17.5M Q1 '21: 1.7M Q2 '21: 5.7M Q3 '21: 5.8M Q1 '22: 5.8M Q2 '22: 7M Q3 '22: 7.1M Q1 '23: 8.3M Q2 '23: 9.1M Q3 '23: 9.4M Q1 '24: 9.4M Q2 '24: 626.7K Q3 '24: 1.3M Q1 '25: 1.3M Q2 '25: 1.3M Q3 '25: 2.9M Q1 '26: 5M Q2 '26: 5.2M Q2 '13 Q2 '21 Q2 '22 Q2 '23 Q2 '24 Q2 '25 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-18.00 -12.00 -6.00 0.00 6.00 12.00 18.00 Q1 '20: -0.84 Q2 '20: -0.73 Q3 '20: -0.72 Q4 '20: -10.08 Q3 '22: -7.18 Q4 '22: -5.17 Q1 '23: -4.03 Q2 '23: -3.77 Q3 '23: -3.27 Q4 '23: -2.18 Q1 '24: -2.02 Q2 '24: -9.05 Q3 '24: -12.44 Q4 '24: -14.73 Q1 '25: -17.36 Q2 '25: -11.87 Q3 '25: -9.27 Q4 '25: -7.76 Q1 '26: -5.45 Q2 '26: -3.84 Q2 '20 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.